Omini develops a biosensor platform that allows the simultaneous detection of multiple biomarkers.
Omini has raised $150K in total funding. The most recent round was Seed. The last funding was announced in September 2026.
Omini's investors include Bpifrance, Entrepreneurs First, HeartX, EIC Accelerator, Angels Santé.
Omini is headquartered in Paris, France.
Omini develops a biosensor platform that allows the simultaneous detection of multiple biomarkers.
Omini is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Omini — Funding & Investors." VCBacked, September 28, 2026, https://www.vcbacked.co/company/omini. Accessed October 20, 2026.
VCBacked. (2026). Omini — Funding & Investors. Retrieved October 20, 2026, from https://www.vcbacked.co/company/omini
{{cite web |title=Omini — Funding & Investors |url=https://www.vcbacked.co/company/omini |website=VCBacked |access-date=October 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated